L J Reece1, P Sachdev2, R J Copeland3, M Thomson4, J K Wales5, N P Wright6. 1. Centre for Sport and Exercise Science, Sheffield Hallam University, Sheffield, South Yorkshire, UK. 2. Academic Unit of Child Health, University of Sheffield, Sheffield, South Yorkshire, UK. 3. The National Centre for Sport and Exercise Medicine and The Centre for Sport and Exercise Science, Sheffield Hallam University, Sheffield, South Yorkshire, UK. 4. Department of Gastroenterology, Sheffield Children's Hospital, Sheffield, South Yorkshire, UK. 5. Service Group Director Endocrinology & Nephrology, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia. 6. Department of Endocrinology, Sheffield Children's Hospital, Sheffield, South Yorkshire, UK.
Abstract
BACKGROUND: Severe adolescent obesity (body mass index (BMI) >99.6th centile) is a significant public health challenge. Current non-invasive treatments, including community-based lifestyle interventions, are often of limited effectiveness in this population, with NICE guidelines suggesting the use of bariatric surgery as the last line of treatment. Health professionals are understandably reluctant to commission bariatric surgery and as an alternative, the use of an intra-gastric balloon as an adjunct to a lifestyle programme might offer a reversible, potentially safer and less invasive option. OBJECTIVES: Explore the use of an intra-gastric balloon as an adjunct to a lifestyle support programme, to promote weight loss in severely obese adolescents. Outcomes included weight loss, waist and hip measurements, psychosocial outcomes including health-related quality of life (HRQoL) and physical self perceptions, physical activity and cardiorespiratory fitness. METHOD: Non-randomised pilot study. RESULTS: Twelve severely obese adolescents (5 males, 7 females; mean age 15 years; BMI >3.5 s.d.; puberty stage 4 or more) and their families were recruited. Mean weight loss at 12 months (n=9) was 3.05 kg±14.69; d=0.002, P=0.550, and a BMI Z-score (n=12) change of 0.2 s.d.; d=0.7, P=0.002 was observed at 6 months with a large effect, but was not sustained at 12 months (mean change 0.1 s.d.; d=0.3, P=0.146). At 24 months (n=10), there was a weight gain from baseline of +9.9 kg±1.21 (d=0.4; P=0.433). Adolescent and parent HRQoL scores exceeded the minimal clinical important difference between baseline and 12 months for all domains but showed some decline at 24 months. CONCLUSION: An intra-gastric balloon as an adjunct to a lifestyle support programme represents a safe and well-tolerated treatment approach in severely obese adolescents, with short-term effects on weight change. Improvements in psychosocial health, physical activity and cardiorespiratory fitness were maintained at 12 months, with varying results at 24 months.
BACKGROUND:Severe adolescent obesity (body mass index (BMI) >99.6th centile) is a significant public health challenge. Current non-invasive treatments, including community-based lifestyle interventions, are often of limited effectiveness in this population, with NICE guidelines suggesting the use of bariatric surgery as the last line of treatment. Health professionals are understandably reluctant to commission bariatric surgery and as an alternative, the use of an intra-gastric balloon as an adjunct to a lifestyle programme might offer a reversible, potentially safer and less invasive option. OBJECTIVES: Explore the use of an intra-gastric balloon as an adjunct to a lifestyle support programme, to promote weight loss in severely obese adolescents. Outcomes included weight loss, waist and hip measurements, psychosocial outcomes including health-related quality of life (HRQoL) and physical self perceptions, physical activity and cardiorespiratory fitness. METHOD: Non-randomised pilot study. RESULTS: Twelve severely obese adolescents (5 males, 7 females; mean age 15 years; BMI >3.5 s.d.; puberty stage 4 or more) and their families were recruited. Mean weight loss at 12 months (n=9) was 3.05 kg±14.69; d=0.002, P=0.550, and a BMI Z-score (n=12) change of 0.2 s.d.; d=0.7, P=0.002 was observed at 6 months with a large effect, but was not sustained at 12 months (mean change 0.1 s.d.; d=0.3, P=0.146). At 24 months (n=10), there was a weight gain from baseline of +9.9 kg±1.21 (d=0.4; P=0.433). Adolescent and parent HRQoL scores exceeded the minimal clinical important difference between baseline and 12 months for all domains but showed some decline at 24 months. CONCLUSION: An intra-gastric balloon as an adjunct to a lifestyle support programme represents a safe and well-tolerated treatment approach in severely obese adolescents, with short-term effects on weight change. Improvements in psychosocial health, physical activity and cardiorespiratory fitness were maintained at 12 months, with varying results at 24 months.
Authors: Angela Celio Doyle; Andrea Goldschmidt; Christina Huang; Andrew J Winzelberg; C Barr Taylor; Denise E Wilfley Journal: J Adolesc Health Date: 2008-05-02 Impact factor: 5.012
Authors: Zhaoping Li; Margaret Maglione; Wenli Tu; Walter Mojica; David Arterburn; Lisa R Shugarman; Lara Hilton; Marika Suttorp; Vanessa Solomon; Paul G Shekelle; Sally C Morton Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: Shauna M Burke; Sheree Shapiro; Robert J Petrella; Jennifer D Irwin; Michelle Jackman; Erin S Pearson; Harry Prapavessis; Joel Kevin Shoemaker Journal: BMC Obes Date: 2015-05-14
Authors: Janey S A Pratt; Allen Browne; Nancy T Browne; Matias Bruzoni; Megan Cohen; Ashish Desai; Thomas Inge; Bradley C Linden; Samer G Mattar; Marc Michalsky; David Podkameni; Kirk W Reichard; Fatima Cody Stanford; Meg H Zeller; Jeffrey Zitsman Journal: Surg Obes Relat Dis Date: 2018-03-23 Impact factor: 4.734
Authors: Aaron S Kelly; Marsha D Marcus; Jack A Yanovski; Susan Z Yanovski; Stavroula K Osganian Journal: Int J Obes (Lond) Date: 2018-10-03 Impact factor: 5.095
Authors: P Sachdev; L Reece; M Thomson; A Natarajan; R J Copeland; J K Wales; N P Wright Journal: Int J Obes (Lond) Date: 2017-09-05 Impact factor: 5.095
Authors: Michelle I Cardel; Mark A Atkinson; Elsie M Taveras; Jens-Christian Holm; Aaron S Kelly Journal: JAMA Pediatr Date: 2020-06-01 Impact factor: 16.193
Authors: Jennifer Ce Lane; Katherine L Butler; Jose Luis Poveda-Marina; Daniel Martinez-Laguna; Carlen Reyes; Jeroen de Bont; Muhammad Kassim Javaid; Jennifer Logue; Juliet E Compston; Cyrus Cooper; Talita Duarte-Salles; Dominic Furniss; Daniel Prieto-Alhambra Journal: J Bone Miner Res Date: 2020-04-07 Impact factor: 6.390